Hosted on MSN
GSK nixes application for drug touted by Trump for autism
GSK withdrew its application for a drug touted last year by President Trump as a potential treatment for autism symptoms, just months after the company submitted it at the request of health officials.
FDA Withdraws GSK’s Approval of Drug Touted as Autism Treatment
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug.
Becker's Hospital Review
Pharma company withdraws FDA application amid White House autism treatment push
GSK, a biopharmaceutical company, has withdrawn its application to the FDA for leucovorin calcium tablets, months after the White House promoted the drug as a potential treatment for autism-related ...
Bloomberg L.P.
FDA Withdraws GSK’s Approval of Drug Touted as Autism Treatment
US regulators have withdrawn their approval of a GSK Plc drug that the Trump administration had promoted as a treatment for autism, adding another twist to the unusual story of a decades-old drug. The ...